|
Surmodics Inc (NASDAQ: SRDX) |
|
Surmodics Inc
SRDX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Surmodics Inc 's sales fell
by -46.18 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 16
Medical Equipment & Supplies industry recorded
deterioration of revenues by -14.66 %
Surmodics Inc faced net loss in contrast to the net income a year ago in I. Quarter 2024
• More on SRDX's Growth
|
|
Surmodics Inc realized a net loss in trailing twelve months.
Surmodics Inc realized cash reduction of $ -1.62 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 3.95.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.54.
• More on SRDX's Valuation
|
|
|
|
|
Surmodics Inc realized net loss in trailing twelve months.
Surmodics Inc realized cash outflow of $ -1.62per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 3.95.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.54.
Surmodics Inc Price to Book Ratio is at 4.34 higher than Industry Avg. of -179.66, and higher than S&P 500 Avg. of 0.01
• More on SRDX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com